Glenmark Takes Full Control of Ryaltris in US, Bets on Direct Market Strategy
Glenmark Pharmaceuticals has announced a strategic shift to directly commercialise and distribute its nasal spray Ryaltris in the United States, moving away from its earlier partner-led model.
Ryaltris In US | 02/04/2026 | By Darshana | 708
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy